AQP4 and demyelinating disease: Neurological syndromes associated with MOG- and AQP4-antibodies now appear as two separate demyelinating diseases, characterized by distinct pathophysiology: AQP4-NMOSD is an astrocytopathy while MOGAD currently appears as an oligodendrogliopathy [18].